Reagents for The Olink® Signature Q100 system
Closed Pre-Solicitation Posted
- Solicitation number
- 25-007622
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center, specifically the Critical Care Medicine Department, intends to procure reagents for the Olink Signature Q100 system on a sole source basis from Olink Proteomics Inc. The reagents are required to study protein biomarkers in patient samples using the department's existing Olink Signature Q100 system, which will only operate effectively with original equipment manufacturer products. The procurement includes three specific reagent types: Olink Target 96 Inflammation, Olink 96.96 IFC for Protein Expression, and Olink Target 96 Organ Damage. This is a notice of intent rather than a solicitation, meaning no formal quotations will be requested at this time. The government is allowing interested parties capable of providing similar products to submit capability statements by June 20, 2025, at 12:45 pm EST to determine whether competitive procurement should be conducted.
This procurement does not utilize any set-aside designations and is being conducted under FAR Part 13 Simplified Acquisition Procedures for purchases not exceeding the simplified acquisition threshold. Olink Proteomics Inc., located in Waltham, Massachusetts, is identified as the sole source contractor and registered trademark holder of the required reagents. The specific quantities needed include 3 units of Olink Target 96 Inflammation reagents, 6 units of Olink 96.96 IFC for Protein Expression reagents, and 3 units of Olink Target 96 Organ Damage reagents. The procurement falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and Product Service Code 6550 for In Vitro Diagnostic Substances. No specific contract value or budget range has been disclosed in this pre-solicitation notice.
Notice text
Reagents for The Olink® Signature Q100 system
- Product Service Code: 6550
- NAICS Code: 325413
- Place of Performance:
Bethesda, MD 20892
POTS: 25-007622
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH), Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department (CCMD) intends to award a fixed price Purchase Order to Olink Proteomics Inc. located at 130 Turner St. Building 2, Suite 230 Waltham, MA 02453 on a sole source basis for the procurement of reagents for the Olink® Signature Q100 system used by the Critical Care Medicine Department (CCMD) at the NIH Clinical Center (CC) to process samples and for data analysis.
The Critical Care Medicine Department currently owns the Olink® Signature Q100 system. This system is a unique technology that will only operate effectively with genuinely manufactured parts and supplies. The reagents are being purchased to study protein biomarkers in patient samples. Olink reagents are the only products that are compatible with the equipment, and use of any other reagents would jeopardize the functionality of the equipment. The Olink System reagents are not interchangeable with other manufacturer's reagents. Due to the ongoing research, it is imperative that the Critical Care Medicine Department continue with Original Equipment Manufacturer (OEM) products to ensure that the equipment operates properly and accurately for the outcome of the research. Olink Proteomics is the registered trademark holder and only known distributor of the Olink® reagents.
The below items are required for this action:
Description/Product Code/Quantity:
Olink® Target 96 Inflammation/ Product Code: 95302 / QTY: 3
Olink® 96.96 IFC for Protein Expression / Product Code: 95007 / QTY: 6
Olink® Target 96 Organ Damage / Product Code: 95331 / QTY: 3
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested Parties:
Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Comments:
Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date June 20, 2025, (12:45 pm EST) and time marked in this notice.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – AB Sciex LLC | NIH Clinical Center | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| Notice of Intent to Sole Source – Boston Scientific | NIH Clinical Center | No set-aside | |
| Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests. | Veterans Integrated Service Network 20 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity